The Latest

Company News

October 12, 2022

Inceptor Bio and Avectas Announce Collaboration to Improve Manufacturing of CAR-T Cell Therapies for the Treatment of Solid Tumors

Arrow

Read More

Company News

June 30, 2022

Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform

Arrow

Read More

Company News

May 19, 2022

Inceptor Bio Announces $37 Million Series A Financing

Arrow

Read More

Company News

December 16, 2021

Inceptor Bio Enters into In-licensing Agreement For CAR-M Platform

Arrow

Read More

Company News

October 27, 2021

Inceptor Bio Announces Agreement to Acquire Gainesville, FL GMP Facility And Transfer Operating Team From Arranta Bio

Arrow

Read More

Company News

June 14, 2021

Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers

Arrow

Read More